Erasmus GBS Respiratory Insufficiency Score (EGRIS)
The validated predictive scoring system used to assess the risk of respiratory failure requiring intubation/mechanical ventilation in Guillain-Barré syndrome is the Erasmus GBS Respiratory Insufficiency Score (EGRIS). [1]
Medication Selection Algorithm
EGRIS is a clinical prognostic score that assigns risk based on early respiratory and bulbar/functional features to estimate the likelihood of subsequent need for mechanical ventilation. [1]
Key Evidence Supporting This Recommendation
In a prospective validation study, EGRIS distinguished patients who required mechanical ventilation from those who did not with an AUC of 0.81. [1] The observed mechanical ventilation probability was 20%, while the model-predicted probability was 41%, with recalibration improving calibration. [1] EGRIS validation specifically evaluated respiratory failure requiring mechanical ventilation within a short time window after study entry. [1]
Monotherapy vs Combination Therapy
EGRIS is used as a prognostic risk stratification tool rather than a treatment strategy. [1] EGRIS is typically applied alongside clinical monitoring to support timing decisions for airway management. [1]
Important Clarifications or Nuances
EGRIS was also evaluated in a later study as part of respiratory failure prediction model frameworks, including investigation of added prognostic value from biomarkers to clinical respiratory risk models. [2] Regional model adjustment and recalibration have been reported to address overestimation of respiratory failure risk in specific cohorts. [1]
Initiation Thresholds or Indications
EGRIS is applied to identify patients at increased risk for respiratory failure requiring mechanical ventilation during the early phase of Guillain-Barré syndrome. [1]
Common Pitfalls to Avoid
Using EGRIS without accounting for potential calibration differences across settings can lead to risk overestimation, as demonstrated by the 41% vs 20% discrepancy prior to intercept updating. [1]
Targets or Goals of Therapy
The clinical goal of EGRIS-based risk stratification is to support timely escalation of respiratory support decisions to prevent delayed intubation in patients progressing to respiratory failure. [1]